10-K: CareCloud, Inc. Reports 2023 Financial Results, Suspends Preferred Stock Dividends Amidst Restructuring

CareCloud, Inc. reported a net loss for 2023, suspended preferred stock dividends, and detailed restructuring efforts aimed at improving profitability and cash flow.

Summary

• CareCloud, Inc. reported a net loss of $48.7 million for the year ended December 31, 2023, a significant decrease compared to a net income of $5.4 million in 2022.
• The company's revenue decreased by 16% to $117.1 million in 2023 from $138.8 million in 2022, primarily due to the loss of two large accounts and a decrease in professional services revenue.
• The company incurred a goodwill impairment charge of $42 million in 2023, contributing to the net loss.
• In December 2023, CareCloud suspended dividends on its Series A and Series B preferred stock to conserve cash.
• The company is implementing a restructuring plan to reduce costs, including a reduction in workforce, which is expected to improve free cash flow by approximately $10 million annually.
• Despite the net loss, the company had positive cash flow from operations of $15.5 million in 2023.
• The company's offshore operations in Pakistan and Sri Lanka accounted for approximately 9% of total expenses in 2023.
• The company's customer renewal rate was 91% in 2023, down from 98% in 2022.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to significant financial losses, a decrease in revenue, and the suspension of preferred stock dividends. While restructuring efforts are underway, the overall tone is cautious and reflects substantial challenges.

Positives

• The company had positive cash flow from operations of $15.5 million in 2023.
• Restructuring efforts are expected to improve free cash flow by $10 million annually.
• The company is focused on reducing costs and returning to profitability.
• The company has a significant federal NOL carry forward of approximately $274 million.

Negatives

• The company reported a net loss of $48.7 million for 2023.
• Revenue decreased by 16% year-over-year.
• A $42 million goodwill impairment charge was recorded in 2023.
• Preferred stock dividends were suspended in December 2023.
• The company's customer renewal rate decreased to 91% in 2023 from 98% in 2022.
• The company has a working capital deficit of $57,000.

Risks

• The company operates in a highly competitive industry.
• The company's offshore operations are subject to political and economic risks.
• Changes in the healthcare industry could affect the demand for the company's services.
• The company may be unable to retain customers following acquisitions.
• The company may be subject to liability for the content it provides to customers and their patients.
• The company's security measures may be breached, leading to unauthorized access to customer data.
• The company's use of artificial intelligence could result in reputational harm or legal liability.
• The company may be unable to execute accretive acquisitions due to the current stock prices.
• The company may be unable to continue to pay dividends on the Preferred Stock if it falls out of compliance with loan covenants.
• The company's goodwill may be subject to further impairment in the future.

Future Outlook

The company is focused on reducing costs, returning to profitability, generating positive cash flow, and maintaining compliance with debt covenants. Management believes that these initiatives will enable the company to continue as a going concern through at least the next twelve months.

Management Comments

• Management has considered its plans to continue the Company as a going concern and believes substantial doubt is alleviated by focusing on cost-control.
• Management developed a plan that was substantially implemented during fiscal 2023 to improve liquidity in its operations through reductions in payroll and operating expenses.
• Management continues to focus on the Company's overall profitability, including managing expenses, and to the extent possible growing revenue, and expects that these efforts will continue to enhance our liquidity and financial position.

Industry Context

The healthcare IT market is highly competitive, with increasing consolidation and pricing pressures. The company faces competition from larger healthcare IT companies and regional RCM providers. The industry is also experiencing a shift towards value-based care models and increasing regulatory requirements, which present both challenges and opportunities for CareCloud.

Comparison to Industry Standards

• CareCloud competes with larger healthcare IT companies such as athenahealth, Inc., eClinicalWorks, Greenway Medical Technologies, Inc., NextGen, R1 RCM and Veradigm, all of which may have greater resources and brand recognition.
• The company's competitive edge could be diminished if competitors develop similar offshore operations in countries with lower labor costs.
• The company's unique business model includes a cost-effective offshore workforce, which provides a competitive advantage compared to other revenue cycle management companies.
• The company's ability to deliver industry-leading solutions at competitive prices is due to a combination of proprietary software and a global team.
• The company's restructuring efforts are aimed at improving profitability and cash flow, which is a common goal for companies in the healthcare IT sector.

Legal Proceedings

• An arbitrator rendered a decision in favor of Ramapo Anesthesiologists, PC, awarding them $117,000 in mitigation costs, of which the company's portion is approximately $32,000.

Related Party Transactions

• The company leases its corporate offices and other facilities from its Executive Chairman.
• The company had sales to a related party, a physician who is the wife of the Executive Chairman.
• The company entered into a consulting agreement with an entity owned and controlled by a former non-independent director.

Stakeholder Impact

• Shareholders will be negatively impacted by the net loss and suspension of preferred stock dividends.
• Employees may be affected by the workforce reduction as part of the restructuring plan.
• Customers may experience changes in service delivery as the company implements its restructuring plan.
• Creditors may be concerned about the company's financial performance and ability to meet its obligations.

Next Steps

• The company will continue to implement its restructuring plan to reduce costs and improve profitability.
• The company will focus on generating positive cash flow and maintaining compliance with debt covenants.
• The company will continue to assess the market landscape and seek new opportunities to meet the needs of clients.
• The company will continue to enhance its solutions with new functionality and features.

Key Dates

Keywords

healthcare IT, revenue cycle management, EHR, practice management, SaaS, artificial intelligence, telehealth, financial results, restructuring, preferred stock, dividends, goodwill impairment, cost reduction, profitability